Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P17
Within normal range
vs 2Y Ago
-6.5x
Contraction
Streak
2 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -112.12% |
| Q3 2025 | -120.00% |
| Q2 2025 | -126.32% |
| Q1 2025 | 159.09% |
| Q4 2024 | 175.86% |
| Q3 2024 | 32.56% |
| Q2 2024 | 18.87% |
| Q1 2024 | 8.62% |
| Q4 2023 | 17.14% |
| Q3 2023 | 1.41% |
| Q2 2023 | -18.33% |
| Q1 2023 | -1.69% |
| Q4 2022 | -5.36% |
| Q3 2022 | -1.82% |
| Q2 2022 | -7.84% |
| Q1 2022 | 0.00% |
| Q4 2021 | -18.60% |
| Q3 2021 | 88.15% |
| Q2 2021 | -1151.72% |
| Q1 2021 | 67.78% |
| Q4 2020 | -200.00% |
| Q3 2020 | -20.00% |
| Q2 2020 | -25.00% |
| Q1 2020 | 0.00% |